Page 4 - Vaccination

German Parliament rejects mandatory Covid vaccination for those over 60

Germany's lower house of parliament, the Bundestag, has rejected to make Covid-19 vaccination mandatory for adults aged 60 years or older

India crosses 1.85-bn Covid vaccination coverage milestone on Tuesday

A total of 99,04,28,218 doses of first dose and 83,60,22,063 second doses have been administered so far

Biological E to get mRNA technology from WHO to produce Covid vaccines

At present, India has no Covid-19 vaccine made on mRNA platform

India sailed through Omicron wave because of vaccination: Mandaviya

India effectively handled the Omicron wave, which caused numerous deaths in other countries, because of better Covid management and massive vaccination drive, Mandaviya said

Data shows India's changing Covid-19 mix as share of omicron samples dips

Govt stopped updating weekly numbers on genetic sequencing in January

Over 1.84 billion Covid vaccine doses administered in India: Govt

Over 1.59 crore (1,59,51,459) vaccine doses have so far been administered to beneficiaries in the age group of 12-14 years

Delhi sees 112 new Covid cases, one death in a day; positivity rate 0.41%

On multiple days in March so far, the city has recorded no deaths

Over 10 mn kids in age group of 12-14 yrs received first vaccine dose: Govt

The next phase of vaccination commenced from January 3 for adolescents in the age group of 15-18 years

Covid-19: Govt says no state has reported deaths due to oxygen shortage

The Government of India is supporting states in their endeavour to enhance preparedness and response capacities against Covid-19

Over 1.82 billion Covid vaccine doses administered in India: Govt

The country launched vaccination for all people aged above 45 years from April 1 last year

Moderna says its low-dose Covid vaccine shots work for kids under 6

The younger the child, the smaller the dose being tested. Moderna said a quarter of the dose it uses for adults worked well for youngsters under age 6

Four vaccines approved for those below 18 years, govt tells Rajya Sabha

The Central Drugs Standard Control Organization in consultation with Subject Expert Committee has approved four COVID-19 vaccines for restricted use in emergency situation for those aged below 18 years, the Rajya Sabha was informed on Tuesday. The four vaccines which have been approved are Zydus Cadila's ZyCovD (in the age group of 12 years and older), Bharat Biotech's Covaxin (for >2 to <18 years age group), Biological E's Corbevax (for =5 to <18 years age group) and Serum Institute of India's Covovax (for >12 to <18 years age group), Minister of State for Health Bharati Pravin Pawar said in a written reply. The National COVID-19 vaccination programme was expanded to include adolescents aged 15 to 18 years from January 3, 2022. It was further expanded to children of age group 12 -14 years from March 16. The National Covid vaccination programme is guided by National Technical Advisory Group on Immunization (NTAGI) and the National Expert Group on Vaccine ...

162.9 million Covid vaccine doses supplied to 98 countries: Govt

India had supplied 162.9 million Covid-19 vaccine doses to 98 countries as on February 21, the government informed Parliament on Tuesday.

Will India go for mixing vaccines for booster shot? Decision soon

A third shot that does not match the first two doses may be allowed

Djokovic added to draw, unclear if he can play at Indian Wells: Organisers

Djokovic's refusal to get vaccinated against Covid-19 may once again have significant implications with regard to his eligibility to play later this week

Malaria to pneumonia vaccines: SII now betting on non-Covid shots

SII has the capacity to produce 250 million monthly doses of Covishield

Moderna, WHO set for vaccine clash as patents threaten mRNA use

Medecins Sans Frontiers and other health and relief groups are calling on the vaccine-maker to abandon three patent applications filed years ago in South Africa

Third Covid vaccine dose advised for immunocompromised people: BMJ study

The research, published in The BMJ, reinforces the importance of additional doses of the COVID-19 vaccine to protect people with a weakened immune system

Booster dose: Dose gap, natural infection slow offtake among 60-plus

Experts are also questioning the nine-month gap between the second and the third doses

US Covid-19 vaccination drive is bottoming out as Omicron subsides

About 76% of the US population has received at least one shot; less than 65% of all Americans are fully vaccinated